Your browser doesn't support javascript.
loading
A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell lines.
Shah, Ashish H; Suter, Robert; Gudoor, Pavan; Doucet-O'Hare, Tara T; Stathias, Vasileios; Cajigas, Iahn; de la Fuente, Macarena; Govindarajan, Vaidya; Morell, Alexis A; Eichberg, Daniel G; Luther, Evan; Lu, Victor M; Heiss, John; Komotar, Ricardo J; Ivan, Michael E; Schurer, Stephan; Gilbert, Mark R; Ayad, Nagi G.
Affiliation
  • Shah AH; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Suter R; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Gudoor P; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Doucet-O'Hare TT; Neuro-Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Stathias V; Department of Molecular and Cellular Pharmacology, University of Miami, Miami, Florida, USA.
  • Cajigas I; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • de la Fuente M; Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Govindarajan V; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Morell AA; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Eichberg DG; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Luther E; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Lu VM; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Heiss J; Surgical Neurology Division, NINDS National Institute of Health, Bethesda, Maryland, USA.
  • Komotar RJ; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Ivan ME; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Schurer S; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
  • Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Ayad NG; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
Neurooncol Adv ; 4(1): vdab192, 2022.
Article in En | MEDLINE | ID: mdl-35118385
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Neurooncol Adv Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Neurooncol Adv Year: 2022 Document type: Article Affiliation country: Country of publication: